NASDAQ · METX
Consumer Defensive · Education & Training Services
$2.03
Up+$0.12 (+6.28%)
Updated Aug 15, 2026, 3:46 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
METX does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning METX.
METX research
Company profile and research snapshot.
Meten Holding Group Ltd. provides English language training (ELT) services in the People's Republic of China. It operates through four segments: General Adult English Training, Overseas Training Services, Online English Training, and Junior English Training. The company delivers English language and future skills training for Chinese students and professionals. It offers adult and junior ELT services under the Meten brand name; junior ELT services under the Meten and ABC brand names; and online live streaming ELT courses under the Likeshuo brand name through a digital platform and network of learning centers. The company is also involved in the cryptocurrency mining, mining farm construction, and mining pool and data center operation activities. As of December 31, 2021, it had a network of 34 self-operated learning centers covering 15 cities in nine provinces, autonomous regions, and municipalities, as well as two franchised learning centers covering two cities in two provinces and municipalities. The company was formerly known as Meten EdtechX Education Group Ltd. and changed its name to Meten Holding Group Ltd. in August 2021. Meten Holding Group Ltd. was founded in 2006 and is headquartered in Shenzhen, the People's Republic of China.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 28, 2021 | Aegis Capital | Buy | — |
No generated briefing is available yet.
businesswire.com · Sep 26, 2025
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $METX--ME Therapeutics secures U.S. patent for lead candidate and advances broader therapeutic programs.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning METX.
No results
No recent SID articles mention METX.
